Document Detail


2008 Emily Cooley Memorial Lecture: lessons learned from pediatric transfusion medicine clinical trials . . . a little child shall lead them.
MedLine Citation:
PMID:  19527476     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Many clinical practices in transfusion medicine are controversial and/or lack definitive guidelines established by sound clinical trials. Although recommendations based on results of clinical trials performed using infants and children may not always be applied directly to adults--and vice versa--lessons learned from pediatric trials can be useful when critically assessing the design/results/conclusions of adult trials.
STUDY DESIGN AND METHODS: Four randomized clinical trials (RCTs) studying pediatric patients were critically reviewed. They addressed two red blood cell (RBC) transfusion issues: 1) transfusion guidelines by which RBC transfusions are "triggered" by liberal (LIB; high pretransfusion patient hematocrit [Hct] levels) versus being "triggered" by restricted (RES; low pretransfusion Hct levels) and 2) transfusion of fresh RBCs (<or=7 days' storage) versus RBCs (up to 42 days' storage).
RESULTS: Findings established by primary outcomes generally were firm (e.g., fewer RBC transfusions were given to infants/children managed by RES guidelines; transfusing small volumes of RBCs stored up to 42 days to preterm infants diminished allogeneic donor exposures and were equally efficacious and safe as fresh RBCs stored <or=7 days). Findings based on secondary outcomes, subset, and post hoc analyses were inconsistent (e.g., clinical outcomes were equivalent after LIB or RES transfusions in only two of three RCTs; in the third, more neurologic problems were found in neonates given RES transfusions).
CONCLUSIONS: Clinical practices should be based on data pertaining to the primary outcomes of RCTs, because trials are designed and statistically powered to address these issues. Clinical practices suggested by analysis of secondary outcomes, subsets of patients, and post hoc analyses should be applied cautiously until studied further-ideally, as primary outcomes in subsequent RCTs.
Authors:
Ronald G Strauss
Related Documents :
16607006 - Volume replacement in infants with dengue hemorrhagic fever/dengue shock syndrome.
19706136 - A comparative cohort study on transfusion practice and outcome in two dutch tertiary ne...
14567836 - Neonatal transfusion malaria requiring exchange transfusion.
7039516 - Screening for cystic fibrosis by died blood spot trypsin assay.
7803326 - Clinical determination of maturity of newborn infants: comparison of some simplified me...
11207976 - Microsporum canis tinea capitis in an 8-month-old infant successfully treated with 2 we...
Publication Detail:
Type:  Lectures; Research Support, N.I.H., Extramural     Date:  2009-06-10
Journal Detail:
Title:  Transfusion     Volume:  49     ISSN:  1537-2995     ISO Abbreviation:  Transfusion     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-09-08     Completed Date:  2009-09-23     Revised Date:  2013-06-02    
Medline Journal Info:
Nlm Unique ID:  0417360     Medline TA:  Transfusion     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1996-2004     Citation Subset:  IM    
Affiliation:
Department of Pathology, University of Iowa Hospitals & Clinics, Iowa City, Iowa 52242-1009, USA. ronald-strauss@uiowa.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age Factors
Blood Preservation / methods,  standards
Child
Child, Preschool
Erythrocyte Transfusion / adverse effects,  standards
Erythrocytes / cytology
Guidelines as Topic
Hematocrit
Humans
Infant
Infant, Newborn
Randomized Controlled Trials as Topic*
Time Factors
Grant Support
ID/Acronym/Agency:
#P01-HL46925/HL/NHLBI NIH HHS; P01 HL046925-130008/HL/NHLBI NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A case report of severe visceral beta2-microglobulin-derived amyloidosis without obvious joint sympt...
Next Document:  Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus amon...